Busulphan-Cyclophosphamide Cause Endothelial Injury, Remodeling of Resistance Arteries and Enhanced Expression of Endothelial Nitric Oxide Synthase

• Sulaiman Al-Hashmi,

  Affiliation Experimental Cancer Medicine (ECM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Piet J. M. Boels,

  Affiliations 3Ph_S Biomedical, Stockholm, Sweden, Division Genetic Physiology, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Fahad Zadjali,

  Affiliation Department of Molecular Medicine and Surgery (MMK), CMM, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Behnam Sadeghi,

  Affiliation Experimental Cancer Medicine (ECM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Johan Sällström,

  Affiliation 3Ph_S Biomedical, Stockholm, Sweden

  ⨯
• Kjell Hultenby,

  Affiliation EMIL, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Zuzana Hassan,

  Affiliations Experimental Cancer Medicine (ECM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden, Clinincal Research Center, Karolinska University Hospital-Huddinge, Stockholm, Sweden

  ⨯
• Anders Arner,

  Affiliation 3Ph_S Biomedical, Stockholm, Sweden

  ⨯
• Moustapha Hassan

  * E-mail: moustapha.hassan@ki.se

  Affiliations Experimental Cancer Medicine (ECM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden, Clinincal Research Center, Karolinska University Hospital-Huddinge, Stockholm, Sweden

  ⨯